Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc (INDV) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · INDV · as of Mar 31, 2025
Ownership Breakdown
119
Institutional Holders
▲ 1 vs Q4
$866.77M
Total Inst. Value
▼ $108.32M vs Q4
124.77M
Shares Outstanding
freeFloat 90.34%
91.34M
13F Shares Held
▲ 13.78M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
INDV largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
TWO SEAS CAPITAL LP pharmaceutical preparations | 11.37M | 9.19% | 9.19% | $106.51B | May 15, 2025 | ▼ 1.09M |
OAKTREE CAPITAL MANAGEMENT LP pharmaceutical preparations | 11.01M | 8.90% | 8.90% | $103.45B | May 15, 2025 | ▲ 2.28M |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 10.57M | 8.54% | 8.54% | $100.71B | May 15, 2025 | ▲ 1.68M |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 8.37M | 6.77% | 6.77% | $79.76B | Jun 27, 2025 | ▲ 1.30M |
MADISON AVENUE PARTNERS, LP pharmaceutical preparations | 7.79M | 6.30% | 6.30% | $74.26B | May 15, 2025 | ▲ 4.12M |
VANGUARD GROUP INC pharmaceutical preparations | 4.63M | 3.74% | 3.74% | $43.77B | May 9, 2025 | ▲ 71.5K |
RUBRIC CAPITAL MANAGEMENT LP pharmaceutical preparations | 3.53M | 2.85% | 2.85% | $33.64B | May 14, 2025 | ▲ 2.17M |
UBS GROUP AG pharmaceutical preparations | 3.53M | 2.85% | 2.85% | $33.61B | May 13, 2025 | ▲ 2.69M |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 2.47M | 1.99% | 1.99% | $23.50B | May 15, 2025 | ▲ 1.23M |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 2.27M | 1.84% | 1.84% | $21.65B | May 14, 2025 | ▲ 2.05M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
22
Increased
+21.41M shares6
New Positions
first time holders19
Decreased
−7.90M shares0
Sold Out
fully exitedNet shares change (top 50)
+13.51M
+21.41M / −7.90M
Net new holders
+9
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
INDV insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Thompson Juliet director | May 13, 2026 | Award | 6,518 | — | — | 13.0K | Form 4 ↗ |
Thompson Juliet director | May 12, 2026 | Tax Withhold | 1,117 | $38.28 | $42.8K | 6.5K | Form 4 ↗ |
Humphreys Keith director | May 13, 2026 | Award | 6,518 | — | — | 16.0K | Form 4 ↗ |
Kingsley Stuart A director | May 13, 2026 | Award | 6,518 | — | — | 12.1K | Form 4 ↗ |
NINIVAGGI DANIEL A director | May 13, 2026 | Award | 6,518 | — | — | 27.2K | Form 4 ↗ |
Ryan Barbara director | May 13, 2026 | Award | 6,518 | — | — | 12.2K | Form 4 ↗ |
Stejbach Mark director | May 13, 2026 | Award | 6,518 | — | — | 27.1K | Form 4 ↗ |
Wheadon David E. director | May 13, 2026 | Award | 10,430 | — | — | 30.8K | Form 4 ↗ |
Preblick Ryan Chief Financial Officer | Mar 14, 2026 | Tax Withhold | 2,843 | $31.11 | $88.4K | 320.8K | Form 4 ↗ |
Ryan Barbara director | Mar 13, 2026 | Purchase | 8 | $31.09 | $248.68 | 5.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Indivior Pharmaceuticals Inc (INDV) is primarily owned by institutional investors, who hold approximately 73.2% of total shares outstanding. Company insiders own approximately 9.66%, while retail and public investors account for the remaining 17.13%.
The largest institutional shareholder of Indivior Pharmaceuticals Inc is TWO SEAS CAPITAL LP, holding approximately 11.37 million shares — equal to 9.19% of outstanding shares — as of March 31, 2025.
A total of 119 institutional investors currently hold INDV stock, with a combined institutional value of approximately $866,766,224 as of the most recent 13F filing period.
Frequently asked questions
INDV ownershipIndivior Pharmaceuticals Inc (INDV) is primarily owned by institutional investors, who hold approximately 73.2% of shares. The largest shareholder is TWO SEAS CAPITAL LP with a 9.19% stake. Company insiders hold 9.66%. Data sourced from SEC Form 13F as of March 31, 2025.